MeCure Industries reported 2025 results showing revenue of N77.69 billion, up 69%, with EBIT of N16.43 billion, up 98%, and profit after tax of N6.46 billion, up 177%. The company said it secured approvals for 19 new medicines and expanded into Sierra Leone. Shareholders approved a dividend of 32 kobo per share and agreed to increase the company’s capital-raising plan to N50 billion from N30 billion.